What is behind British American Tobacco stock's recent drop in value today

Traders Union
All News
Financial News
British American Tobacco slides 2.73% today

Highlights

British American Tobacco canceled a new share buyback tranche but continued small-scale repurchases as part of capital return efforts.
Outstanding shares with voting rights now total 2,174,452,815, with 132,976,327 shares held in treasury for regulatory purposes.
Traded under heavy short-term selling pressure, BATS is expected to range between GBX 4,369.00 and GBX 4,489.00, with high probability of a rebound despite mixed momentum and near-oversold signals.

Buyback activity offset by persistent selling and capital management

British American Tobacco canceled a new tranche of its share buyback program and repurchased 95,178 ordinary shares as part of ongoing capital return measures. After this transaction, the company reported 2,174,452,815 ordinary shares in issue with voting rights and retained 132,976,327 shares in treasury to meet UK disclosure and transparency requirements. This activity was accompanied by continued balance sheet management efforts, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, notes the persistent bearish structure in BATS shares, with prices unable to regain lost ground above key MAs. He points out that the canceled buyback tranche and lackluster balance sheet moves have done little to restore investor confidence. Technically, sellers retain control as the stock trades below both MA-20 and MA-50, while the sole support from MA-200 is weak. Short-term indicators like MACD signal latent strength, but overall momentum remains fragmented and unconvincing. "Despite headline buybacks, the ongoing downtrend and weak sentiment leave no immediate case for a sustained reversal," Kharitonov says.

Viktoras Karapetjanc, expert at Traders Union, sees opportunity emerging for BATS after short-term selling pressure. He highlights the company’s capital return policies and active balance sheet management as a strategic positive for long-term holders. Karapetjanc stresses that with momentum indicators flashing strong buy signals, a technical base is likely being formed near current levels. "I expect further growth as bullish structure remains intact — investors should watch for renewed upside in the coming weeks," he affirms.

Bearish bias persists amid technical divergence and high intraday volatility

The current price of BATS at GBX 4,268.00 is trading well below the MA-20 (GBX 4,483.35) and MA-50 (GBX 4,348.48), with only the MA-200 (GBX 4,049.89) acting as distant long-term support. This setup signals sustained short- and medium-term seller pressure, while the Ichimoku Kijun at GBX 4,467.50 marks the nearest dynamic resistance. Momentum indicators paint a mixed picture: MACD shows a strong buy bias on the daily timeframe, but ADX reflects weak trend strength. Both RSI and Stoch RSI indicate the stock is approaching oversold territory, with CCI confirming a neutral-to-soft tone. Sellers currently dominate intraday action according to BBP, and today’s GBX 120.00 drop (down 2.73%) came after a gap lower at the open. Price currently sits near the lower end of the intraday range, highlighting high volatility and persistent pressure since the session began. There is a clear divergence between strong momentum signals and negative intraday price action, underscoring conflicting short-term forces.

Previously it was reported that British American Tobacco experienced short-term selling pressure, trading below its 20-day moving average but remaining above both its 50- and 200-day averages, with mixed momentum signals including a bullish daily MACD and moderately bullish RSI, while support near the MA-50 has helped define a consolidation range. Should the price overcome immediate resistance at the Ichimoku Kijun, a move toward the upper end of the current range is likely, whereas renewed selling below the MA-50 would expose firmer support closer to $4,300.

Source of Data: BATS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.